alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This Schedule  contains  summary  financial  information for the year ended
     September 30, 1998  extracted from the  registrant's  annual report on Form
     10-KSB and is qualified in its entirety by reference to such Form 10-KSB.
</LEGEND>
<CIK>                         0000822418
<NAME>                        Bio-Imaging Technologies, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              SEP-30-1998
<PERIOD-START>                                 OCT-01-1997
<PERIOD-END>                                   SEP-30-1998
<EXCHANGE-RATE>                                1
<CASH>                                         1,527,330
<SECURITIES>                                   0
<RECEIVABLES>                                  691,376
<ALLOWANCES>                                   65,000
<INVENTORY>                                    0
<CURRENT-ASSETS>                               2,238,453
<PP&E>                                         4,435,545
<DEPRECIATION>                                 2,892,111
<TOTAL-ASSETS>                                 3,814,122
<CURRENT-LIABILITIES>                          975,695
<BONDS>                                        26,808
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    104
<COMMON>                                       1,944
<OTHER-SE>                                     2,809,571
<TOTAL-LIABILITY-AND-EQUITY>                   3,814,122
<SALES>                                        0
<TOTAL-REVENUES>                               3,599,313
<CGS>                                          0
<TOTAL-COSTS>                                  2,025,868
<OTHER-EXPENSES>                               3,387,224
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             (88,223)
<INCOME-PRETAX>                                (1,725,556)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (1,725,556)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (1,725,556)
<EPS-PRIMARY>                                  (0.23)<F1>
<EPS-DILUTED>                                  (0.23)<F2>
<FN>                                    
<F1>  This amount represents Basic Earnings per Share in accordance with the
      requirements of Statement of Financial Accounting Standards No. 128 -
      "Earnings per Share."
<F2>  This amount represents Diluted Earnings per Share in accordance with the
      requirements of Statement of Financial Accounting Standards No. 128 -
      "Earnings per Share."
</FN>
        

</TABLE>
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Physiology and Pathology of Tree Fruits Research: Wenatchee, WA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Wenatchee, Washington Physiology and Pathology of Tree Fruits Research People & Locations







Delaney R Anderson
                        Physiology and Pathology of Tree Fruits Research

                        




                        
                        Biological Science Technician
                        Phone: (509) 664-2280
                         ext. 205
                        
                        Fax: (509) 664-2287(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
<PAGE>

                                                                    EXHIBIT 99.1



               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                      OF THE SARBANES - OXLEY ACT OF 2002



         In connection with the Quarterly Report of Noble International, Ltd.
("Noble") on Form 10-Q for the period ending June 30, 2002, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Robert
J. Skandalaris, Chief Executive Officer of Noble, certify, pursuant to 18 U. S.
C. section 1350, as adopted pursuant to section 906 of the Sarbanes - Oxley Act
of 2002, to my knowledge that:

     1.  The Report fully complies with the requirements of Section 13 (a) or 15
         (d) of the Securities Exchange Act of 1934; and

     2.  The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         Noble.



Dated:  August 14, 2002                     /s/ Robert J. Skandalaris
                                            --------------------------------
                                            Robert J. Skandalaris
                                            Chief Executive Officer









                                                                              20
#### In the Matter of William J. Drohan.

Concur — Sandler, J. P., Fein, Milonas, Ellerin and Wallach, JJ.
EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection  with the Annual  Report of CNH Holdings  Company on Form
10-KSB for the period  ending March 31, 2004, as filed with the  Securities  and
Exchange  Commission on the date hereof (the "Report"),  I, Cindy Garr,  Interim
C.F.O.of the Company,  certify,  pursuant to 18 U.S.C.  Section 1350, as adopted
pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002, that, to the best of
my knowledge and belief:

         (1)      the Report fully  complies  with the  requirements  of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      the information  contained in the Report fairly  presents,  in
                  all material respects,  the financial  condition and result of
                  operations of the Company.


/s/    Cindy Garr
Cindy Garr
Interim C.F.O.,
Executive Vice-President of Corporate Development,
and Director
(Principal Financial Officer)


July 12, 2004


A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   12-MOS                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1998             SEP-30-1997
<PERIOD-START>                             OCT-01-1997             OCT-01-1996
<PERIOD-END>                               SEP-30-1998             SEP-30-1997
<CASH>                                         739,596                 940,716
<SECURITIES>                                         0                       0
<RECEIVABLES>                                   76,547                 193,876
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                               816,143               1,134,592
<PP&E>                                       2,451,752               1,234,422
<DEPRECIATION>                               (591,577)               (341,683)
<TOTAL-ASSETS>                               2,676,318               2,027,331
<CURRENT-LIABILITIES>                          358,362                 356,989
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                        35,900                  35,900
<OTHER-SE>                                   2,282,056               1,634,442
<TOTAL-LIABILITY-AND-EQUITY>                 2,676,318               2,027,331
<SALES>                                              0                       0
<TOTAL-REVENUES>                             2,617,198               1,993,745
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                             1,607,728               1,308,324
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                              1,009,470                 685,421
<INCOME-TAX>                                   361,856                 291,239
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   647,614                 394,182
<EPS-PRIMARY>                                      .18                     .11
<EPS-DILUTED>                                        0                       0
        

</TABLE>
Kathryn Tassinari, OSB # 80115

Brent Wells, OSB # 85403 

HARDER, WELLS, BARON & MANNING, P.C. 

474 Willamette Street 

Eugene, OR 97401 

(541) 686-1969 

kathrynt50@comcast.net 

Of Attorneys for the Plaintiff 

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF OREGON 

RUSSELL WITT, ) 

) Case No. 6:14-cv-01338-SI

Plaintiff, ) 

vs. ) 

) ORDER FOR PAYMENT OF ATTORNEY 

COMMISSIONER, ) FEES PURSUANT TO EAJA 

Social Security Administration , ) 

) 

) 

____________Defendant._________)

Based upon the Stipulation of the parties, it is hereby ORDERED that attorney fees in the 

amount of $4,870.57 are hereby awarded to Plaintiff, pursuant to the Equal Access to Justice Act 

(EAJA), 28 U.S.C. § 2412. Payment of this award shall be paid via check made payable to 

Plaintiff and mailed to Plaintiff’s attorneys at Harder, Wells, Baron & Manning, P.C., 474 

Willamette Street, Eugene, Oregon 97401. Pursuant to Astrue v. Ratliff, the award shall be made 

payable to Plaintiff’s attorney if the commissioner confirms that Plaintiff owes no debt to the 

government through the federal treasury offset program. There are no costs or expenses to be 

paid herein. 

Dated this day of July 2016. 

_____________________________

_ U.S. District Judge

PRESENTED BY: 

s/ Kathryn Tassinari 

Harder, Wells, Baron & Manning, P.C. 

Of Attorneys for Plaintiff

11th 

/s/ Michael H. Simon

Case 6:14-cv-01338-SI Document 28 Filed 07/11/16 Page 1 of 1
[Federal Register Volume 86, Number 160 (Monday, August 23, 2021)]
[Notices]
[Pages 47202-47203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17946]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee, Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act 5 U.S.C. App. 2, that a meeting of the 
Genomic Medicine Program Advisory Committee (the Committee) will be 
held virtually on Wednesday, September 29, 2021. The meeting will begin 
at 11:30 a.m. EDT and adjourn at 3:30 p.m. EDT. The meeting is open to 
the public via Webex https://veteransaffairs.webex.com/veteransaffairs/j.php?MTID=m6736a5cdd10c19acb461d7de4d05eec6 password: n4XHwEk9y$8 or 
by phone at call-in +14043971596, meeting code: 1990514106##.
    The Committee's purpose is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on using genetic 
information to optimize medical care for Veterans and enhance the 
development of tests and treatments for diseases particularly relevant 
to Veterans.
    On September 29, 2021, the Committee will receive updated briefings 
on various VA research programs, including the Million Veteran Program 
(MVP), to ascertain the program's progress in the areas of participant 
recruitment, data generation and storage, and data access. The 
Committee will also receive updates from ongoing MVP research, 
including a collaboration with the Department of Energy on suicide 
genetics, an update on precision oncology, and the VA Data Commons 
framework. Additionally, the Committee will discuss and explore 
potential recommendations for the next annual report.
    Public comments will be received at 3:00 p.m. EDT and are limited 
to 5 minutes each. Individuals who speak are invited to submit a 1-2 
page summary of their comments for inclusion in the official meeting 
record to Jennifer Moser, Designated Federal Officer, Office of 
Research and Development (14RD), 810 Vermont Avenue NW, Washington, DC 
20420, or at <a href="/cdn-cgi/l/email-protection#baf0dfd4d4d3dcdfc894f7d5c9dfc8faccdb94ddd5cc"><span class="__cf_email__" data-cfemail="753f101b1b1c1310075b381a0610073503145b121a03">[email protected]</span></a>. In the communication, writers must 
identify themselves and state the organization, association, or 
person(s) they represent. Any member of the public who wishes to attend 
the teleconference should RSVP to Jennifer Moser at 202-510-4253 no 
later than close of business, September 23, 2021, at the phone number 
or email address noted above.


[[Page 47203]]


    Dated: August 17, 2021.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-17946 Filed 8-20-21; 8:45 am]
BILLING CODE P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Section 3. In the event of an increase or decrease in the authorized number of directors,(a) each director then serving as such shall nevertheless continue as a director of the Class inwhich he or she is a member until the expiration of his or her current term, or his or her earlierresignation, removal from office or death, and (b) the newly created or eliminated directorshipsresulting from such increase or decrease shall be apportioned by the Board of Directors among thethree Classes of directors so as to maintain such Classes as nearly equal as possible.ARTICLE VDirector Standard of Care and IndemnificationSection 1. The personal liability of an existing or former director or officer-director tothe corporation or its stockholders, or to a subsidiary corporation or its stockholders, formonetary damages for conduct as a director or officer-director is hereby eliminated, provided thatsuch liability shall not be eliminated for acts or omissions that involve intentional misconduct ora knowing violation of law, for conduct violating RCW § 23B.08.310, or for any transaction fromwhich the existing or former director or officer-director will personally receive a benefit inmoney, property, or services to which such person is not legally entitled.Section 2. The corporation shall indemnify an existing or former director orofficer-director made a party to a proceeding by reason of the fact that such person is or was adirector or officer-director and obligate itself to advance or reimburse expenses incurred in anysuch proceeding, all without regard to the limitations in RCW §§ 23B.08.510 through 23B.08.550 andin RCW § 23B.08.560(2), provided that no such indemnity, advance or reimbursement shall be providedfrom or on account of (a) acts or omissions finally adjudged to be intentional misconduct or aknowing violation of law, (b) conduct finally adjudged to be in violation of RCW § 23B.08.310, or(c) any transaction with respect to which it was finally adjudged that such person personallyreceived a benefit in money, property, or services to which such person was not entitled.Section 3. The Board of Directors, by resolution adopted at any regular or specialmeeting, shall make provisions in the corporation’s Bylaws for the matters set forth in thisArticle V.              /s/ William W. Krippaehne, Jr.   William W. Krippaehne, Jr.   President and CEO  
 

 
     **CERTIFICATE TO**
#### The People of the State of New York, Respondent, v Juan Vasquez, Appellant.

[941 NYS2d 853]

Appeal by the defendant from a judgment of the County Court, Westchester County (Zambelli, J.), rendered August 4, 2009, convicting him of criminal sale of a controlled substance in the third degree and criminal possession of a controlled substance in the third degree (two counts), upon a jury verdict, and imposing sentence. The appeal brings up for review the denial, after a hearing (Molea, J.), of that branch of the defendant’s omnibus motion which was to suppress physical evidence.

Ordered that the judgment is affirmed.

Contrary to the defendant’s contention, since the police had probable cause to arrest him, the search of his person was lawful as incident to that arrest *(see People v Inge,*90 AD3d 675 [2011]; *People v Blinker,*80 AD3d 619 [2011]).

The defendant’s challenge to the legal sufficiency of the evidence supporting his convictions is unpreserved for appellate review *(see*CPL 470.05 [2]; *People v Hawkins,*11 NY3d 484, *916492 [2008]). In any event, viewing the evidence in the light most favorable to the prosecution (see *People v Contes,*60 NY2d 620 [1983]), we find that it was legally sufficient to establish the defendant’s guilt beyond a reasonable doubt. Moreover, in fulfilling our responsibility to conduct an independent review of the weight of the evidence (see CPL 470.15 [5]; *People v Danielson,*9 NY3d 342 [2007]), we nevertheless accord great deference to the jury’s opportunity to view the witnesses, hear the testimony, and observe demeanor (see *People v Mateo,*2 NY3d 383, 410 [2004], *cert denied*542 US 946 [2004]; *People v Bleakley,*69 NY2d 490, 495 [1987]). Upon reviewing the record here, we are satisfied that the verdict of guilt was not against the weight of the evidence (see *People v Romero,*7 NY3d 633 [2006]).

The defendant was not deprived of the effective assistance of counsel. The record as a whole demonstrates that the defendant received meaningful representation *(see People v Benevento,*91 NY2d 708 [1998]; *People v Baldi,*54 NY2d 137 [1981]).

The defendant’s remaining contention is without merit. Skelos, J.P, Eng, Belen and Cohen, JJ., concur.
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Riverside, California
 close




            Search small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home People & Locations







Paul  Walker
                        Location Support Staff

                        




                        
                        Maintenance Mechanic
                        Phone: (951) 289-3785
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov